PRAX
Income statement / Annual
Last year (2025), Praxis Precision Medicines Inc's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2025, Praxis Precision Medicines Inc's net income was -$303.27 M.
See Praxis Precision Medicines Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$8.55 M |
$2.45 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$140.00 K
|
$152.41 M
|
$86.77 M
|
$154.44 M
|
$0.00
|
$0.00
|
$679.00 K
|
$1.00 K
|
| Gross Profit |
-$140.00 K
|
-$143.86 M
|
-$84.32 M
|
-$154.44 M
|
$0.00
|
$0.00
|
-$679.00 K
|
-$1.00 K
|
| Gross Profit Ratio |
0
|
-16.82
|
-34.46
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$267.12 M
|
$152.41 M
|
$86.77 M
|
$155.04 M
|
$120.26 M
|
$44.98 M
|
$29.56 M
|
$18.82 M
|
| General & Administrative Expenses |
$59.08 M
|
$56.31 M
|
$42.05 M
|
$59.55 M
|
$47.08 M
|
$16.99 M
|
$6.23 M
|
$3.90 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$59.08 M
|
$56.31 M
|
$42.05 M
|
$59.55 M
|
$47.08 M
|
$16.99 M
|
$6.23 M
|
$3.90 M
|
| Other Expenses |
$0.00
|
-$152.41 M
|
-$86.77 M
|
-$154.04 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$326.06 M
|
$56.31 M
|
$42.05 M
|
$60.55 M
|
$167.33 M
|
$61.97 M
|
$35.79 M
|
$22.72 M
|
| Cost And Expenses |
$326.20 M
|
$208.72 M
|
$128.82 M
|
$214.99 M
|
$167.33 M
|
$61.97 M
|
$35.79 M
|
$22.72 M
|
| Interest Income |
$22.93 M
|
$17.35 M
|
$0.00
|
$0.00
|
$0.00
|
$140.00 K
|
$193.00 K
|
$92.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$127.00 K
|
| Depreciation & Amortization |
$140.00 K
|
$358.00 K
|
$432.00 K
|
$419.00 K
|
$182.00 K
|
$50.00 K
|
$679.00 K
|
$1.00 K
|
| EBITDA |
-$303.13 M |
-$199.81 M |
-$125.94 M |
-$213.57 M |
-$167.15 M |
-$61.92 M |
-$34.92 M |
-$26.27 M |
| EBITDA Ratio |
0
|
-23.36
|
-51.47
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
-23.4
|
-51.64
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$22.93 M
|
$17.35 M
|
$3.10 M
|
$957.00 K
|
$271.00 K
|
$140.00 K
|
$193.00 K
|
-$3.68 M
|
| Income Before Tax |
-$303.27 M
|
-$182.82 M
|
-$123.28 M
|
-$214.03 M
|
-$167.06 M
|
-$61.83 M
|
-$35.60 M
|
-$26.40 M
|
| Income Before Tax Ratio |
0
|
-21.37
|
-50.38
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$8.00 K
|
-$84.00 K
|
$133.00 K
|
| Net Income |
-$303.27 M
|
-$182.82 M
|
-$123.28 M
|
-$214.03 M
|
-$167.06 M
|
-$61.82 M
|
-$35.51 M
|
-$26.54 M
|
| Net Income Ratio |
0
|
-21.37
|
-50.38
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-13.48 |
-10.21 |
-18.69 |
-69.33 |
-58.96 |
-103.61 |
-348.24 |
-306.73 |
| EPS Diluted |
-13.48 |
-10.21 |
-18.69 |
-69.33 |
-58.96 |
-103.61 |
-348.24 |
-306.73 |
| Weighted Average Shares Out |
$22.50 M
|
$17.91 M
|
$6.59 M
|
$3.07 M
|
$2.83 M
|
$596.68 K
|
$101.98 K
|
$86.51 K
|
| Weighted Average Shares Out Diluted |
$22.50 M
|
$17.91 M
|
$6.59 M
|
$3.07 M
|
$2.83 M
|
$596.68 K
|
$101.98 K
|
$86.51 K
|
| Link |
|
|
|
|
|
|
|
|
